Submerged Bioprinting - 3D-Printing of cell-containing hydrogel structures with high geometrical complexity
Submerged Bioprinting - 3D-Printing of cell-containing hydrogel structures with high geometrical complexity
A German university offers a technology to print the conduits submerged in dense non-miscible solvents, such as fluorocarbons. It is characterised by a superior performance compared to conventional methods: Viable cells were shown 24 hours after the printing process, as well as after 21 days in culture. Industrial partners are sought for licensing agreements.
Bioprinting technologies recently appeared as important tissue engineering alternatives for regenerative medicine and organ transplantation. This novel approach for printing of tissues substitutes is based on the submersion of simultaneously printed cell-hydrogel structures into a non-toxic perfluorodecalin liquid substrate. Not only has it been achieved to develop a robotic platform for 3D-printing, but also to combine natural or synthetic hydrogels with human mesenchymal stem cells. A German university developed a technology that allows to print the conduits submerged in non-miscible solvents of high density, such as fluorocarbons (e.g. C12F27N), that support the printed structure while it is being generated. This results in superior performance in relation to other methods. The hydrophobicity and high density of the fluorocarbon help to control the deposition of each individual droplet, resulting in a high degree of precision of the 3D-printed construct, which has been proven to remain long-term stable. Furthermore, live/dead-staining and staining with the fluorescent stain DAPI (4′,6-Diamidin-2-phenylindol,) showed viable cells 24 hours after the printing process, as well as after 21 days in culture. In a special embodiment, the German university’s invention describes a simpler way of reproducing the structural hierarchy of multiple tissue substitutes using an inkjet drop-on-demand (DoD) bioprinting approach. This novel strategy for cell printing can therefore be used in the future for broad applications in the field of tissue engineering and regenerative medicine. In particular the method is suitable for printed tissue substitutes with high geometrical complexity. Partners from biotechnological and pharmaceutical industry are sought for license agreements to use the technology.
Type: Technology Offer
Country: Germany
Profile updated on: 23/05/2022
Profile valid until: 26/11/2022
Partnership
| Development stage | Under development/lab tested |
|---|---|
| Development stage - comment | Technology Readiness Level (TRL) 5. The technology has been validated in relevant environment. |
| Cooperation Ipr Status | Patent(s) applied for but not yet granted,Patents granted |
| Cooperation Ipr Comment | Patent applied for in Europe and US Patent granted in Germany |
| Cooperation Partner Area | Partners are sought for license agreements. Type of partner: Industry: Biotechnology, pharmaceutical industry Role of partner: License in to use and integrate in processes |
| Cooperation Partner Sought |
Company / Organisation
| Organisation type | University |
|---|---|
| Company Turnover | |
| Company Since | 0 |
| Company Transnational | Si |
Technological fields
-
3D printing
ELECTRONICS; IT AND TELECOMMS / Electronic circuits; components and equipment
-
3D printing
INDUSTRIAL MANUFACTURING; MATERIAL AND TRANSPORT / Design and Modelling / Prototypes
-
Pharmaceutical Products / Drugs
BIOLOGICAL SCIENCES / Medicine; Human Health
-
Medical Biomaterials
BIOLOGICAL SCIENCES / Medicine; Human Health
-
Cellular and Molecular Biology
BIOLOGICAL SCIENCES / Biology / Biotechnology
Attachments
| # | File Preview | File name |
|---|---|---|
| 1 | 3D_Prints.jpg | |
| 2 | 3D_Prints.jpg | |
| 3 | 3D_Prints.jpg | |
| 4 | 3D_Prints.jpg | |
| 5 | 3D_Prints.jpg |